Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody-Drug Conjugate Overview: a State-of-the-art Manufacturing Process and Control Strategy
Meng Li, Xueyu Zhao, Chuanfei Yu, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 3, pp. 419-440
Closed Access | Times Cited: 10

Showing 10 citing articles:

Tailored therapies for triple-negative breast cancer: current landscape and future perceptions
Yumna Khan, Sana Rizvi, Ali Raza, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 1
20-Hour Conjugation Bottlenecks – Confronting ADC Development Challenges with CDMOs
Minmin Qin
ADC Review / Journal of Antibody-drug Conjugates (2025)
Open Access
Antibody-drug conjugate combinations in cancer treatment: clinical efficacy and clinical study perspectives
X. Shi, Kai Tang, Quanbin Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Trends in the research and development of peptide drug conjugates: artificial intelligence aided design
Donge Zhang, Tong He, Tianyi Shi, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Research progress of antibody coupling technique in targeted drug delivery
Meng Li, Tiantian Wang, Dan Tan, et al.
Deleted Journal (2025)
Open Access
Current progress and remaining challenges of peptide–drug conjugates (PDCs): next generation of antibody-drug conjugates (ADCs)?
Dongyuan Wang, Feng Yin, Zigang Li, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Dual immunostimulatory CD73 antibody-polymeric cytotoxic drug complex for triple negative breast cancer therapy
Xiao Hua Xie, Ming Yang, Wei Xue, et al.
Acta Biomaterialia (2024) Vol. 189, pp. 532-544
Closed Access | Times Cited: 2
Comparison of target agent treatment strategies for platinum-resistant recurrent ovarian cancer: A Bayesian network meta-analysis
John Leung, Henry W. C. Leung, Shyh-Yau Wang, et al.
Medicine (2024) Vol. 103, Iss. 21, pp. e38183-e38183
Open Access
Next Generation of Antibody-Drug Conjugates for Breast Cancer
Shobhit Srivastava, Azeezat O. Osikoya, Dayanidhi Raman
Interdisciplinary cancer research (2024)
Closed Access
Towards Aptamer-Targeted Drug Delivery to Brain Tumors: The Synthesis of Ramified Conjugates of an EGFR-Specific Aptamer with MMAE on a Cathepsin B-Cleavable Linker
Vladimir A. Brylev, Ekaterina V. Ryabukhina, Evgeniya V. Nazarova, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1434-1434
Open Access
Adenosine monophosphate modified nanomicelles for precise delivery of magnolol enhances chemosensitivity in cancer therapy
Yangfan Zheng, Jiali Deng, Le‐Wei Li, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106559-106559
Closed Access
Page 1

Scroll to top